1-6 of 6
Authors: Yibo Yin
Journal Article
EXTH-23. BICISTRONIC CAR-T CELLS TARGETING EGFR AND IL13RΑ2 MITIGATE ANTIGENIC HETEROGENEITY IN GLIOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii214, https://doi.org/10.1093/neuonc/noac209.822
Published: 14 November 2022
Journal Article
IMMU-36. HIGH AFFINITY CHIMERIC ANTIGEN RECEPTOR WITH CROSS-REACTIVITY TO CLINICALLY-RELEVANT EGFR MUTATED PROTEINS Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii112, https://doi.org/10.1093/neuonc/noaa215.466
Published: 09 November 2020
Journal Article
IMMU-48. RATIONAL DEVELOPMENT AND CHARACTERIZATION OF MULTIVALENT TARGETING TANDEM AND PARALLEL CAR T CELLS FOR GLIOMA Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi129, https://doi.org/10.1093/neuonc/noz175.540
Published: 11 November 2019
Journal Article
IMST-27. CD70–A CRITICAL MEDIATOR OF TUMOR PROGRESSION AND IMMUNOSUPPRESSION IN GLIOMAS Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi92, https://doi.org/10.1093/neuonc/now212.383
Published: 07 November 2016
Journal Article
IMST-25. CD70—A NOVEL TARGET OF CAR-T-CELL THERAPY FOR GLIOMAS Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi91–vi92, https://doi.org/10.1093/neuonc/now212.381
Published: 07 November 2016
Journal Article
IMPS-42CD70—A KEY DRIVER OF CHEMOKINE-MEDIATED IMMUNE SUPPRESSION AND INDICATOR OF NEGATIVE PROGNOSIS FOR GLIOBLASTOMA Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v122, https://doi.org/10.1093/neuonc/nov217.41
Published: 09 November 2015
